Alcon acquires majority stake in Aurion, replaces CEO Greg Kunst with Arnaud Lacoste amid legal battle. Plans Phase 3 trial ...

FDA approves Soleno Therapeutics' diazoxide choline (DCCR) to treat hyperphagia in Prader-Willi syndrome patients, marking ...

The FDA has approved Exelixis' cancer drug Cabometyx to treat advanced neuroendocrine tumors inside and outside of the ...

Actinium Pharmaceuticals holds investor event at Trump's Mar-a-Lago resort, discussing Actimab-A and Iomab-ACT programs. CEO ...

Decades ago, Amber Salzman remembers feeling like there was nothing she could do to help her cousin-in-law with a progressive ...

The Trump administration's threatened tariffs on Europe would be painful for the biotech industry, according to data from a ...

Wave Life Sciences reports positive Phase 2 results for DMD drug WVE-N531, with 7.8% dystrophin expression at 24-48 weeks, ...

ElevateBio cuts workforce by 17%, now employs under 400 people. Company raised largest private biotech funding in 2023 but ...

Duke professor Pranam Chatterjee discusses AI in biology, advocating for sequence-based over structure-based protein models, ...

The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Makary as FDA commissioner, putting him in charge ...

J&J's Rybrevant and Lazcluze combo shows better survival rates vs AstraZeneca's Tagrisso in lung cancer trial, with 56% of ...

Lyndra Therapeutics, backed by Gates Foundation and Gilead, shuts down after failing to secure funding for Phase 3 safety ...